Corporate Governance
The Zur Rose Group applies the principles and rules of Corporate Governance set out in the “Swiss Code of Best Practice for Corporate Governance” of economiesuisse. The content and structure of this section comply with the Directive on Information relating to Corporate Governance issued by the SIX Swiss Exchange. Unless otherwise stated, all information relates to the reporting date of 31 December 2018. The key elements of corporate governance are defined in the Company’s Articles of Association, Organizational Regulations and Terms of Reference of the Committees of the Board of Directors. The Zur Rose Group publishes these documents online at zurrosegroup.com.
HEINZ O. BAUMGARTNER, STEFAN FEUERSTEIN, WALTER OBERHÄNSLI, VANESSA FREY, THOMAS SCHNEIDER, VOLKER AMELUNG.
Board of Directors
Stefan Feuerstein
(1955, German national, Prof.), Chairman of the Board
Chairman of the Board of Partners of the UNIMO-Gerstner Group, Zug / Xanten. Director of various companies. Served as Executive Director and CEO of Markant AG until 2010 and previously as a member of the Management Board of METRO AG, responsible for Strategic Group Purchasing and Food & Retail. He studied business administration and has been an honorary professor at Worms University of Applied Sciences since 2001.
Walter Oberhänsli
(1958, Swiss national, lic. iur., lawyer), Executive Director and CEO
Chairman of the Board from 1996 to 2011, serving as Executive Director and Chief Executive Officer (CEO) since 2005. He practised as an independent lawyer in Kreuzlingen (Canton of Thurgau) until the end of 2004 and studied law at the University of Zurich.
Thomas Schneider
(1955, Swiss national, Dr. med.), Vice Chairman of the Board
Specialist in general medicine (FMH), working as a family and general practitioner in a group practice in Tägerwilen (Canton of Thurgau) since 1989. Served as a member of the Medical Ethics Board of the Thurgau Medical Society in 2009, having previously occupied various roles in professional policy at national and cantonal level. He studied medicine at the University of Basel.
Volker Amelung
(1965, dual German-Swiss national, Univ. Prof. Dr. oec. HSG)
Specialist Professor of International Health Systems Research at Hannover Medical School since 2001, following teaching appointments at the University of Economics and Politics, Hamburg, and Columbia University, New York. He studied business administration at the Universities of St. Gallen and Paris-Dauphine.
Heinz O. Baumgartner
(1963, Swiss national, Dr. oec. HSG)
CEO of Schweiter Technologies AG, Horgen, since 2009. Served at its CFO from 1996 to 2013. Previously worked as a controller at Asea Brown Boveri Switzerland. He graduated in business administration from the University of St. Gallen.
Vanessa Frey
(1980, Swiss national, business economist, MSc in Finance)
CEO and Director of Corisol Holding Ltd. since 2007. Director of various companies. Served in the Corporate Finance Team of Handelsbanken Capital Markets in Stockholm and subsequently as asset manager in Hong Kong from 2004 to 2006. She earned a bachelor’s degree in economics and law from the University of St. Gallen and a Master of Science degree in international economics and business from Stockholm School of Economics.
WALTER HESS, OLAF HEINRICH, WALTER OBERHÄNSLI, MARCEL ZIWICA.
Group Management
Walter Oberhänsli
(1958, Swiss national, lic. iur., lawyer), Executive Director and CEO
Chairman of the Board from 1996 to 2011, serving as Executive Director and Chief Executive Officer (CEO) since 2005. He practised as an independent lawyer in Kreuzlingen (Canton of Thurgau) until the end of 2004 and studied law at the University of Zurich.
Marcel Ziwica
(1975, Swiss national, lic. oec. HSG), Chief Financial Officer (CFO)
Held a variety of management positions in the Zur Rose Group from 2001 to 2014, ultimately as Head of Group Finance and Controlling and a member of the Executive Committee for Switzerland. Serving as CFO since November 2014. Prior to joining the Zur Rose Group, he worked as a consultant with Spider Innoventure Ltd in Tägerwilen. He studied business administration at the University of St. Gallen.
Walter Hess
(1965, Swiss national, business economist), Head for Switzerland
Zur Rose General Manager since March 2015 and also Head for Switzerland within the Zur Rose Group since 2017. Before joining the Group, he worked as an external consultant, also on various projects for Zur Rose, and ultimately heading the Zur Rose Pharma GmbH facility in Halle (Saale). CEO of Praevmedic AG, Zurich, until 2013. Previously held a number of management positions in international industrial companies. After a business education, he studied business administration at FHS St. Gallen University of Applied Sciences.
Olaf Heinrich
(1970, German national, industrial engineer), Head for Germany
Serving on the Management Board of DocMorris since 2008 and as CEO since 2009, additionally appointed Head for Germany within the Zur Rose Group in 2017. Before joining DocMorris, he managed joint ventures in the retail (KarstadtQuelle/Redcats) and pharmaceutical (Medco Celesio) sectors and held other international senior management positions with leading companies in the retail and pharmaceutical sectors. He studied industrial engineering in Berlin and London.